Signalia Foundation was created in response to a condition that challenges how medicine typically works
How We Think
There is no single lens that fully explains FND.
Different fields approach it in different ways—often using different language, frameworks, and assumptions.
Rather than choosing one perspective, we look at how they connect.
We consider:
how the brain functions in real time
how patterns of movement, sensation, and response are learned and reinforced
how attention, expectation, and environment influence symptoms
how patients experience and interpret what is happening in their bodies
These are often treated as separate domains. In practice, they overlap.
Our approach is to follow those connections. Not to reduce FND to a single explanation—but to understand how multiple factors interact to produce real, physical symptoms.
Clarity comes from examining that system as a whole.
How We Work
Our work is shaped by an investigative process.
We begin with questions.
We examine how FND is defined, diagnosed, and treated—and where those approaches align or fall short.
We speak with clinicians, researchers, and people living with the condition to understand how theory translates into real-world experience.
We prioritize clarity over simplicity.
That means:
translating complex information without distorting it
avoiding explanations that are easy, but incomplete
being transparent about uncertainty
We are not building a fixed narrative.
We are building understanding—step by step—and sharing that process as it develops.
Meet the Board
-
Nadine Sebai
BOARD CHAIR
-
William H. Ollinger, Jr.
SECRETARY/TREASURER
-
Miguel Barbosa, CFA
-
Meagan Watson, MPH, MBA
-
Kelly Boylan, MD
-
Beth Rush, PhD, ABPP
-
Kyr Goyette
-
Ranell Shubert